| scholarly article | Q13442814 |
| P2093 | author name string | Rohit Divekar | |
| Ping Yu | |||
| Hyun-Hee Lee | |||
| J Jeremiah Bell | |||
| Habib Zaghouani | |||
| Renu Jain | |||
| Randal K Gregg | |||
| Scott J Schoenleber | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell function | Q95674809 |
| P304 | page(s) | 7308-7316 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. | |
| P478 | volume | 173 |
| Q33384634 | APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development |
| Q33661871 | Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes |
| Q42578734 | Antigen-Specific Immune Modulation Targets mTORC1 Function To Drive Chemokine Receptor-Mediated T Cell Tolerance. |
| Q36920276 | Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance |
| Q35762883 | Antigen-specific therapeutic approaches in Type 1 diabetes |
| Q38184646 | Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives |
| Q38771022 | Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes |
| Q36228247 | B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis |
| Q50322131 | Congenic mapping identifies a novel Idd9 subregion regulating type 1 diabetes in NOD mice |
| Q53560161 | Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. |
| Q39928054 | Disturbances in some gene expression in T regulatory cells separated from children with metabolic syndrome. |
| Q44370377 | Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes |
| Q37359000 | Dysrulation of T cell peripheral tolerance in type 1 diabetes |
| Q33955180 | Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice |
| Q36715704 | Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency |
| Q39752246 | FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes |
| Q26752197 | GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing |
| Q35659179 | Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β. |
| Q33237082 | Highly sensitive and specific bioassay for measuring bioactive TGF-beta |
| Q36881697 | Host resistance and immune responses in advanced age. |
| Q34166274 | Immunomodulation of antigen presenting cells promotes natural regulatory T cells that prevent autoimmune diabetes in NOD mice |
| Q37017265 | Immunosupportive therapies in aging |
| Q33770196 | Induced Regulatory T Cells Superimpose Their Suppressive Capacity with Effector T Cells in Lymph Nodes via Antigen-Specific S1p1-Dependent Egress Blockage |
| Q81150553 | Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes |
| Q51673568 | Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. |
| Q36446935 | Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production |
| Q38691482 | Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation |
| Q36109325 | Mechanisms underlying antigen-specific tolerance of stable and convertible Th17 cells during suppression of autoimmune diabetes |
| Q37737987 | Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease |
| Q38966071 | Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes |
| Q37208578 | Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells |
| Q54309935 | Notch activation on effector T cells increases their sensitivity to Treg cell-mediated suppression through upregulation of TGF-βRII expression. |
| Q38655427 | Novel technologies to engineer graft for tolerance induction |
| Q48228458 | On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes |
| Q35035427 | Phenotypic modulation of auto-reactive cells by insertion of tolerogenic molecules via MSC-derived exosomes |
| Q34178740 | Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease |
| Q83168646 | Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro |
| Q56901937 | Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand |
| Q37030992 | Recovery from overt type 1 diabetes ensues when immune tolerance and β-cell formation are coupled with regeneration of endothelial cells in the pancreatic islets |
| Q37618585 | Regulation of type 1 diabetes, tuberculosis, and asthma by parasites |
| Q36969926 | Regulatory T cells and toll-like receptors: regulating the regulators |
| Q43513695 | Regulatory T-cell therapy: is it ready for the clinic? |
| Q35610749 | Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis |
| Q51567175 | Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice. |
| Q28585423 | Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens |
| Q87409683 | Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice |
| Q36251293 | T cell tolerance induced by therapeutic antibodies |
| Q36989149 | TGFbeta1 and Treg cells: alliance for tolerance |
| Q53357495 | Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. |
| Q36421334 | The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model. |
| Q35569913 | The role of regulatory T cell defects in type I diabetes and the potential of these cells for therapy |
| Q36557587 | Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance |
| Q36434147 | Transforming growth factor-beta: recent advances on its role in immune tolerance |
| Q37220376 | Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells |
| Q41888326 | Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. |
| Q35849658 | Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response |
Search more.